Suchergebnisse - "Freda, Pamela U"

PubPharm (22)

1

The acromegaly lipodystrophy

enthalten in: Frontiers in endocrinology | 2022

von Freda, P.

2

Prognostic value of nadir GH levels for long-term biochemical remission or recurrence in surgically treated acromegaly

enthalten in: Pituitary | 2021

von Freda, P. | Bruce, J. | Reyes-Vidal, C. | +6

3

A Pituitary Society update to acromegaly management guidelines

enthalten in: Pituitary | 2021

von Fleseriu, M. | Biller, B. | Freda, P. | +8

4

Plasma Agouti-Related Protein Levels in Acromegaly and Effects of Surgical or Pegvisomant Therapy

enthalten in: The Journal of clinical endocrinology and metabolism | 2019

von Freda, P. | Reyes-Vidal, C. | Jin, Z. | +4

5

IGF-1 levels across the spectrum of normal to elevated in acromegaly : relationship to insulin sensitivity, markers of cardiovascular risk and body composition

enthalten in: Pituitary | 2015

von Reid, T. | Jin, Z. | Shen, W. | +6

6

Long-term treatment with pegvisomant as monotherapy in patients with acromegaly : experience from ACROSTUDY

enthalten in: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists | 2015

von Freda, P. | Gordon, M. | Kelepouris, N. | +3

CommentIn: Endocr Pract. 2015 Mar;21(3):296-8. - PMID 25667381

7

Prospective study of surgical treatment of acromegaly : effects on ghrelin, weight, adiposity, and markers of CV risk

enthalten in: The Journal of clinical endocrinology and metabolism | 2014

von Reyes-Vidal, C. | Fernandez, J. | Bruce, J. | +6

8

Effectiveness of self- or partner-administration of an extended-release aqueous-gel formulation of lanreotide in lanreotide-naïve patients with acromegaly

enthalten in: Pituitary | 2010

von Salvatori, R. | Nachtigall, L. | Cook, D. | +31

9

Features at diagnosis of 324 patients with acromegaly did not change from 1981 to 2006 : acromegaly remains under-recognized and under-diagnosed

enthalten in: Clinical endocrinology | 2010

von Reid, T. | Post, K. | Bruce, J. | +3

10

Monitoring of acromegaly : what should be performed when GH and IGF-1 levels are discrepant?

enthalten in: Clinical endocrinology | 2009

von Freda, P.